Home A novel exonuclease (TaqMan) assay for rapid haptoglobin genotyping
Article
Licensed
Unlicensed Requires Authentication

A novel exonuclease (TaqMan) assay for rapid haptoglobin genotyping

  • Wilfried Renner EMAIL logo , Renate Jahrbacher , Ernestine Marx-Neuhold , Simone Tischler and Barbara Zulus
Published/Copyright: October 17, 2015

Abstract

Background:

Haptoglobin is an acute-phase binding protein that scavenges free hemoglobin. The human haptoglobin gene (HP) is polymorphic with two main alleles, haptoglobin allele 1 (Hp1) and haptoglobin allele 2 (Hp2). The smaller Hp1 allele features no duplication and consists of four exons, whereas the larger Hp2 allele, containing a 1.7 kb duplication, consists of six exons, with the fifth and sixth being highly homologous to exons 3 and 4 of Hp1.

Methods:

We designed an exonuclease (TaqMan) assay targeting single nucleotide differences between the homologous regions of Hp1 and Hp2. The assay contained one probe specifically binding to a site in intron 4 of Hp2, and another probe binding equally to intron 4 of Hp1 and intron 6 of Hp2.

Results:

Measurement of post-PCR fluorescence allowed unambiguous discrimination of HP genotypes. Comparison with genotypes obtained by a method based upon allele-specific primers yielded fully corresponding results.

Conclusions:

The new HP genotyping method is fast, reliable, does not require real-time instruments and may be especially useful for high-throughput genotyping.


Corresponding author: Prof. Dr. Wilfried Renner, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, 8036 Graz, Austria, Phone: +43 316 385-80291, Fax: +43 316 385-73008, E-mail:

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Garby L, Noyes WD. Studies on hemoglobin metabolism. I. The kinetic properties of the plasma hemoglobin pool in normal man. J Clin Invest 1959;38:1479–83.10.1172/JCI103925Search in Google Scholar PubMed PubMed Central

2. Alayash AI. Haptoglobin: old protein with new functions. Clin Chim Acta 2011;412:493–8.10.1016/j.cca.2010.12.011Search in Google Scholar PubMed

3. Maeda N, Yang F, Barnett DR, Bowman BH, Smithies O. Duplication within the haptoglobin Hp2 gene. Nature 1984;309:131–5.10.1038/309131a0Search in Google Scholar PubMed

4. Levy AP, Asleh R, Blum S, Levy NS, Miller-Lotan R, Kalet-Litman S, et al. Haptoglobin: basic and clinical aspects. Antioxid Redox Signal 2010;12:293–304.10.1089/ars.2009.2793Search in Google Scholar PubMed

5. Yang F, Brune JL, Baldwin WD, Barnett DR, Bowman BH. Identification and characterization of human haptoglobin cDNA. Proc Natl Acad Sci USA 1983;80:5875–9.10.1073/pnas.80.19.5875Search in Google Scholar PubMed PubMed Central

6. Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996;42:1589–600.10.1093/clinchem/42.10.1589Search in Google Scholar

7. Goldenstein H, Levy NS, Levy AP. Haptoglobin genotype and its role in determining heme-iron mediated vascular disease. Pharmacol Res 2012;66:1–6.10.1016/j.phrs.2012.02.011Search in Google Scholar PubMed PubMed Central

8. Costacou T, Levy AP. Haptoglobin genotype and its role in diabetic cardiovascular disease. J Cardiovasc Transl Res 2012;5:423–35.10.1007/s12265-012-9361-zSearch in Google Scholar PubMed PubMed Central

9. Koch W, Latz W, Eichinger M, Roguin A, Levy AP, Schömig A, et al. Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR. Clin Chem 2002;48:1377–82.10.1093/clinchem/48.9.1377Search in Google Scholar

10. Soejima M, Koda Y. TaqMan-based real-time PCR for genotyping common polymorphisms of haptoglobin (HP1 and HP2). Clin Chem 2008;54:1908–13.10.1373/clinchem.2008.113126Search in Google Scholar PubMed

11. Koda Y, Soejima M, Yoshioka N, Kimura H. The haptoglobin-gene deletion responsible for anhaptoglobinemia. Am J Hum Genet 1998;62:245–52.10.1086/301701Search in Google Scholar PubMed PubMed Central

12. Vormittag R, Vukovich T, Mannhalter C, Minar E, Schönauer V, Bialonczyk C, et al. Haptoglobin phenotype 2-2 as a potentially new risk factor for spontaneous venous thromboembolism. Haematologica 2005;90:1557–61.Search in Google Scholar

13. Ko DH, Chang HE, Kim TS, Song EY, Park KU, Song J, et al. A review of haptoglobin typing methods for disease association study and preventing anaphylactic transfusion reaction. Biomed Res Int 2013;2013:390630.10.1155/2013/390630Search in Google Scholar PubMed PubMed Central

14. Soejima M, Koda Y, Fujihara J, Takeshita H. The distribution of haptoglobin-gene deletion (Hpdel) is restricted to East Asians. Transfusion 2007;47:1948–50.10.1111/j.1537-2995.2007.01467.xSearch in Google Scholar PubMed

Received: 2015-6-23
Accepted: 2015-9-21
Published Online: 2015-10-17
Published in Print: 2016-5-1

©2016 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Protein S100B: from cancer diagnostics to the evaluation of mild traumatic brain injury
  4. Reviews
  5. Capillary electrophoresis based on nucleic acid detection for diagnosing human infectious disease
  6. Oxidative damage and the pathogenesis of menopause related disturbances and diseases
  7. Opinion Paper
  8. EFLM WG-Preanalytical phase opinion paper: local validation of blood collection tubes in clinical laboratories
  9. Genetics and Molecular Diagnostics
  10. Effective quality management practices in routine clinical next-generation sequencing
  11. Analysis of PMP22 duplication and deletion using a panel of six dinucleotide tandem repeats
  12. A novel exonuclease (TaqMan) assay for rapid haptoglobin genotyping
  13. General Clinical Chemistry and Laboratory Medicine
  14. Heparinate but not serum tubes are susceptible to hemolysis by pneumatic tube transportation
  15. Criteria of adequacy for vitamin D testing and prevalence of deficiency in clinical practice
  16. A simple clot based assay for detection of procoagulant cell-derived microparticles
  17. Measurement of factor XIII (FXIII) activity by an automatic ammonia release assay using iodoacetamide blank-procedure: no more overestimation in the low activity range and better detection of severe FXIII deficiencies
  18. Immunoassay or LC-MS/MS for the measurement of salivary cortisol in children?
  19. Head to head evaluation of the analytical performance of two commercial methotrexate immunoassays and comparison with liquid chromatography-mass spectrometry and the former fluorescence polarization immunoassay
  20. Reference Values and Biological Variations
  21. Preanalytical, analytical, gestational and pediatric aspects of the S100B immuno-assays
  22. Establishment of reference intervals of clinical chemistry analytes for the adult population in Saudi Arabia: a study conducted as a part of the IFCC global study on reference values
  23. First data on the biological variation and quality specifications for plasma ammonia concentrations in healthy subjects
  24. Cancer Diagnostics
  25. Hypermethylation of DLX4 predicts poor clinical outcome in patients with myelodysplastic syndrome
  26. Cardiovascular Diseases
  27. Galectin-3, osteopontin and successful aging
  28. Platelet volume is associated with the Framingham risk score for cardiovascular disease in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)
  29. Infectious Diseases
  30. Diagnostic values of CD64, C-reactive protein and procalcitonin in ventilator-associated pneumonia in adult trauma patients: a pilot study
  31. Corrigendum
  32. Corrigendum to: Accuracy of GFR estimating equations combining standardized cystatin C and creatinine assays: a cross-sectional study in Sweden
  33. Letters to the Editor
  34. Theranos phenomenon – part 3
  35. Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice
  36. Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice
  37. Impact of specimen mixing methods on presepsin point-of-care test results using whole blood
  38. Clinical laboratories have a critical role in test strip lot management in glucose point-of-care testing
  39. Hemoglobin A2-Leuven (α2δ2 143(H21) His>Asp): a novel delta-chain variant potentially interfering in hemoglobin A1c measurement using cation exchange HPLC
  40. Eryptosis is induced by hyperthermia in hereditary spherocytosis red blood cells
  41. Investigation of sensitivity for coagulation factor deficiency in APTT and PT: how to perform it?
  42. Underestimation of hepcidin concentration by time of flight mass spectrometry and competitive ELISA in hepcidin p.Gly71Asp heterozygotes
  43. Congress Abstracts
  44. ISMD2016 Eleventh International Symposium on Molecular Diagnostics
Downloaded on 14.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2015-0586/html
Scroll to top button